Pancreatic head tumor
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients: Patients aged 18 years or older who will undergo robot-assisted pancreaticoduodenectomy with a diagnosis of pancreatic head region tumor between the date of approval and March 31, 2026 at the Department of Hepatobiliary, Pancreatic and Artificial Organs Transplantation, The University of Tokyo Hospital, and who have given their consent. Control group: Patients who underwent open pancreaticoduodenectomy between January 2008 and September 2023 at the Department of Hepatobiliary and Transplant Surgery, University of Tokyo Hospital.
Exclusion criteria
Exclusion criteria: Patients under 17 years of age. Patients who cannot give consent. For patients undergoing open pancreaticoduodenectomy, those who have requested refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital stays, Complication rates within 30 days, and Readmission rates within 90 days | — |
Countries
Japan
Contacts
The University of Tokyo Hospital Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery